Roger Nitsch
Director/Board Member at LONZA GROUP AG
Net worth: 221 310 $ as of 2024-03-30
Profile
Roger Nitsch is the founder of Evotec International GmbH (founded in 1995), Neurimmune AG (founded in 2006), and NovaGo Therapeutics AG (founded in 2015).
At Evotec International GmbH, he held the title of Director from 1995 to 1998.
At Neurimmune AG, he holds the titles of President, Chief Executive Officer & Director.
At NovaGo Therapeutics AG, he holds the title of Director.
Currently, Dr. Nitsch holds multiple jobs, including Chairman at Neurimmune Holding AG, Independent Director at Lonza Group AG (since 2022), Director at INTEGRA Biosciences AG (since 2002), Director at AL-S Pharma AG, Professor at the Institute For Regenerative Medicine (since 1998), and Professor at the University of Zurich (since 2018).
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
LONZA GROUP AG
0.00% | 2023-12-30 | 369 ( 0.00% ) | 221 310 $ | 2024-03-30 |
Roger Nitsch active positions
Companies | Position | Start |
---|---|---|
LONZA GROUP AG | Director/Board Member | 2022-04-30 |
AL-S Pharma AG
AL-S Pharma AG Pharmaceuticals: MajorHealth Technology AL-S Pharma AG engages in the development and marketing of pharmaceutical products. The company was founded by Michael Salzmann on September 19, 2016 and is headquartered in Schlieren, Switzerland. | Director/Board Member | - |
NovaGo Therapeutics AG
NovaGo Therapeutics AG Pharmaceuticals: MajorHealth Technology NovaGo Therapeutics AG is a biotechnology start-up company, which engages in the development and manufacture of human antibody products. It focuses on cerebral stroke and spinal cord injury to stimulate nerve repair and regeneration. Its offering includes recombinant human monoclonal antibodies targeting the nerve outgrowth inhibitor Nogo-A. The company was founded by Martin E. Schwab and Roger M. Nitsch and is headquartered in Schlieren, Switzerland. | Founder | 2014-12-31 |
Neurimmune AG | Founder | 2005-12-31 |
Neurimmune Holding AG
Neurimmune Holding AG Pharmaceuticals: MajorHealth Technology Neurimmune Holding AG is a Swiss pharmaceutical company that was founded in 2006. The private company is based in Schlieren, Switzerland and has subsidiaries in Switzerland. Neurimmune Holding manufactures pharmaceutical products. | Chairman | - |
Integra Biosciences AG
Integra Biosciences AG Medical SpecialtiesHealth Technology Integra Biosciences AG manufactures and distributes laboratory equipment. Its products include manual, electronic pipettes, micro plate dispensers, peristaltic pump and aspiration systems. The company is headquartered in Zizers, Switzerland. | Director/Board Member | 2001-12-31 |
University of Zurich | Corporate Officer/Principal | 2017-12-31 |
Institute For Regenerative Medicine
Institute For Regenerative Medicine Miscellaneous Commercial ServicesCommercial Services Institute For Regenerative Medicine is a non-profit organization. It focuses on regenerative medicine and cell therapy. The company as founded in August 2008 and is headquartered in College Station, TX. | Corporate Officer/Principal | 1997-12-31 |
Former positions of Roger Nitsch
Companies | Position | End |
---|---|---|
Evotec International GmbH
Evotec International GmbH Miscellaneous Commercial ServicesCommercial Services Evotec International GmbH develops and provides drugs for the treatment of CNS disorders. It focuses on Alzheimer's disease and other neurological disorders. The company was founded in 1999 and is headquartered in Hamburg, Germany. | Founder | 1997-12-31 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
LONZA GROUP AG | Health Technology |
Private companies | 7 |
---|---|
Institute For Regenerative Medicine
Institute For Regenerative Medicine Miscellaneous Commercial ServicesCommercial Services Institute For Regenerative Medicine is a non-profit organization. It focuses on regenerative medicine and cell therapy. The company as founded in August 2008 and is headquartered in College Station, TX. | Commercial Services |
Evotec International GmbH
Evotec International GmbH Miscellaneous Commercial ServicesCommercial Services Evotec International GmbH develops and provides drugs for the treatment of CNS disorders. It focuses on Alzheimer's disease and other neurological disorders. The company was founded in 1999 and is headquartered in Hamburg, Germany. | Commercial Services |
Integra Biosciences AG
Integra Biosciences AG Medical SpecialtiesHealth Technology Integra Biosciences AG manufactures and distributes laboratory equipment. Its products include manual, electronic pipettes, micro plate dispensers, peristaltic pump and aspiration systems. The company is headquartered in Zizers, Switzerland. | Health Technology |
Neurimmune Holding AG
Neurimmune Holding AG Pharmaceuticals: MajorHealth Technology Neurimmune Holding AG is a Swiss pharmaceutical company that was founded in 2006. The private company is based in Schlieren, Switzerland and has subsidiaries in Switzerland. Neurimmune Holding manufactures pharmaceutical products. | Health Technology |
AL-S Pharma AG
AL-S Pharma AG Pharmaceuticals: MajorHealth Technology AL-S Pharma AG engages in the development and marketing of pharmaceutical products. The company was founded by Michael Salzmann on September 19, 2016 and is headquartered in Schlieren, Switzerland. | Health Technology |
NovaGo Therapeutics AG
NovaGo Therapeutics AG Pharmaceuticals: MajorHealth Technology NovaGo Therapeutics AG is a biotechnology start-up company, which engages in the development and manufacture of human antibody products. It focuses on cerebral stroke and spinal cord injury to stimulate nerve repair and regeneration. Its offering includes recombinant human monoclonal antibodies targeting the nerve outgrowth inhibitor Nogo-A. The company was founded by Martin E. Schwab and Roger M. Nitsch and is headquartered in Schlieren, Switzerland. | Health Technology |
Neurimmune AG |
- Stock Market
- Insiders
- Roger Nitsch